Qube Research & Technologies (QRT)
PRNB

Qube Research & Technologies (QRT)’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,767
Closed -$224K – 2106
2020
Q1 		$224K Sell
3,767
-7,929
-68% -$462K 0.01% 828
2019
Q4 		$641K Buy
+11,696
New +$437K 0.02% 835

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRNB Position: Q2 2020 in Review

Qube Research & Technologies (QRT) sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q2 2020, closing a stake of 3,767 shares — an estimated $224K sold.

Qube Research & Technologies (QRT) first reported a position in PRNB in Q4 2019 and held it in 2 quarters. The position peaked at $641K in Q4 2019. 137 funds tracked by Wall St. Rank hold PRNB as of Q2 2020.

  • Qube Research & Technologies (QRT) reported no remaining Principia Biopharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3,767 Principia Biopharma Inc. Common Stock shares in Q2 2020, an estimated $224K.
  • Qube Research & Technologies (QRT) first reported a position in Principia Biopharma Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Principia Biopharma Inc. Common Stock position peaked at $641K in Q4 2019.
  • 137 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q2 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2020, filed 14 Aug 2020.